Imaging of Patients With Known or Suspected Somatostatin Receptor Positive Neuroendocrine Tumors Using Cu64-DOTATATE
Clinical trial NCT03673943 · COMPLETED
Trial details
- NCT number
- NCT03673943
- Sponsor
- Radiomedix, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-23
- Primary completion
- 2019-03-23
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.